immuno-oncology

Lilly and Merck Expand Immuno-Oncology Collaboration
Yahoo
Wed, 01/11/17 - 10:05 am
Eli Lilly
Merck
immuno-oncology
Lartruvo
Keytruda
Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Xtalks
Mon, 11/7/16 - 09:17 pm
immuno-oncology
heart damage
Opdivo
Yervoy
Bristol-Myers Squibb
anti-PD-1 immunotherapy
Pfizer's Bold Bid to Conquer Cancer
Motley Fool
Wed, 08/17/16 - 09:16 am
Pfizer
cancer
immuno-oncology
The ‘don’t eat me’ antidote: GlaxoSmithKline, Roche and Novo back $86M startup in high-stakes CD47 showdown
Endpoints
Tue, 08/16/16 - 11:16 am
GSK
Roche
Novo Nordisk
Tioma Therapeutics
CD47
immuno-oncology
CAR-T therapies: the future of cancer care, or an industry pipe dream?
Medical Marketing and Media
Mon, 07/25/16 - 10:09 am
CAR-T
cancer
immuno-oncology
As immuno-oncology therapies evolve, so will the marketing
Medical Marketing and Media
Mon, 07/25/16 - 10:06 am
immuno-oncology
3 Ways This $30 Billion Market Is Bristol's for the Taking
Motley Fool
Tue, 06/21/16 - 11:16 pm
Bristol-Myers Squibb
immuno-oncology
Opdivo
Bristol-Myers And MD Anderson Cancer Center Makes Fresh Research Alliance In Immuno-Oncology Focused On Lung-Cancer
Yahoo/Benzinga
Wed, 06/8/16 - 09:35 am
Bristol-Myers Squibb
MD Anderson Cancer Center
R&D
immuno-oncology
Celgene expands partnership with Agios into immuno-oncology
BioPharma Dive
Wed, 05/18/16 - 11:59 am
Celgene
Agios Pharmaceuticals
immuno-oncology
AG-120
Pfizer, Merck begin triple-drug immuno-oncology study
BioPharma Dive
Wed, 05/11/16 - 10:43 am
Pfizer
Merck
immuno-oncology
avelumab
Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Roche
ASCO
immuno-oncology
Amgen
Merck
Bristol-Myers Squibb
Keytruda: Merck’s New Blockbuster for Its Immuno-Oncology Franchise
Yahoo/Market Realist
Sun, 03/6/16 - 11:33 am
Keytruda
Merck
immuno-oncology
melanoma
non-small cell lung cancer
Drugmakers partner in immuno-oncology, to better capture market share
Medical Marketing and Media
Wed, 03/2/16 - 11:00 am
Opdivo
immuno-oncology
Bristol-Myers Squibb
Eli Lilly
Merck
Roche
AstraZeneca
Novartis
Bristol-Myers Looks To A Promising Future
Yahoo/Benzinga
Wed, 02/17/16 - 10:43 am
Bristol-Myers Squibb
immuno-oncology
Roche looks ahead to immuno-oncology, MS to back up big-selling cancer meds
Fierce Pharma
Fri, 01/29/16 - 08:23 pm
Roche
MS
multiple sclerosis
immuno-oncology
Merck teams with Affimed on immuno-oncology combo
Fierce Biotech
Mon, 01/25/16 - 10:01 pm
Merck
Affimed
immuno-oncology
Baxalta strikes a $1.6B immuno-oncology deal ahead of potential Shire deal
BioPharma Dive
Tue, 01/5/16 - 11:20 am
Baxalta
Shire
M&A
immuno-oncology
Symphogen
R&D
Novartis poaches a Harvard oncologist to head up immuno-oncology program
BioPharma Dive
Thu, 12/17/15 - 02:01 pm
Novartis
Harvard
immuno-oncology
Bristol-Myers Squibb and UCLA Enter into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Research Program
Yahoo
Mon, 12/14/15 - 11:01 am
Bristol-Myers Squibb
UCLA
R&D
immuno-oncology
Pfizer bets up to $1B on BioAtla's approach to immuno-oncology
Fierce Biotech
Wed, 12/9/15 - 09:39 am
Pfizer
BioAtla
immuno-oncology

Pages